IL-13 Targeting Biologics for the Treatment of Atopic Dermatitis - Episode 13
Data With IL-13– Targeting Agents in Atopic Dermatitis in Clinical Practice
Published on:
Panelists discuss switching from dupilumab to other IL-13 inhibitors in atopic dermatitis (AD), reviewing real-world data (RWD) on the effectiveness, safety, and patient outcomes associated with these treatments.
Video content above is prompted by the following:
- Can you talk about switching from dupilumab and other RWD with IL-13 agents in AD?
